Author Question: Where is Iguau Falls located? A) on the Paran River, where Brazil, Argentina, and Paraguay meet ... (Read 35 times)

K@

  • Hero Member
  • *****
  • Posts: 608
Where is Iguau Falls located?
 
  A) on the Paran River, where Brazil, Argentina, and Paraguay meet
  B) on the Amazon River in central Brazil
  C) on the Orinoco River in Venezuela
  D) between Mexico and Guatemala
  E) on the Magdalena River in Colombia

Question 2

What is an altiplano?
 
  A) Caribbean marine ecosystems
  B) large cave and pothole systems
  C) cool, moist, flat areas for agriculture or grazing
  D) desert areas along the Pacific Coast
  E) none of the above



wshriver

  • Sr. Member
  • ****
  • Posts: 318
Answer to Question 1

Answer: A

Answer to Question 2

Answer: C



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

Did you know?

There are major differences in the metabolism of morphine and the illegal drug heroin. Morphine mostly produces its CNS effects through m-receptors, and at k- and d-receptors. Heroin has a slight affinity for opiate receptors. Most of its actions are due to metabolism to active metabolites (6-acetylmorphine, morphine, and morphine-6-glucuronide).

Did you know?

Approximately 25% of all reported medication errors result from some kind of name confusion.

Did you know?

Looking at the sun may not only cause headache and distort your vision temporarily, but it can also cause permanent eye damage. Any exposure to sunlight adds to the cumulative effects of ultraviolet (UV) radiation on your eyes. UV exposure has been linked to eye disorders such as macular degeneration, solar retinitis, and corneal dystrophies.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library